MARKET EYE-Indian shares flat; pharma shares fall

Fri Nov 23, 2012 10:21am IST

Related Topics

Stocks

   

* The BSE index and the NSE index flat, as
investors wait for announcements regarding proposed bills to
open up the insurance, pension and banking sectors in the
ongoing winter session of parliament.
* On Thursday India approved a new drug pricing policy designed
to increase the number of drugs deemed essential that are
subject to price caps, a move that will curtail prices. 
    
* GlaxoSmithKline Pharmaceuticals down 1.2 percent,
Ranbaxy Laboratories falls 0.3 percent.  
* The NSE bank index that gained 1.78 percent outperforming the
50 share NSE index in the last three trading sessions was
trading lower, ICICI Bank down 0.4 percent.
* Hindustan Copper Ltd down 12.46 percent, after
government set the base price at 155 rupees a share for its 4
percents stake sale, way below Thursday's closing price of
266.15 rupees.   

 (manoj.dharra@thomsonreuters.com)
FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

India Economy

REUTERS SHOWCASE

Reliance Projects

Reliance Projects

Exclusive: Reliance plans $13 billion projects including new refinery.  Full Article 

Chopper Deal

Chopper Deal

India nears $2.5 billion deal for Boeing military helicopters.  Full Article 

Coal Scam

Coal Scam

CBI drops coal scam case against Kumar Mangalam Birla.  Full Article 

Low Stocks

Low Stocks

Indian power station coal stocks lowest since 2012 blackouts.  Full Article 

Markets This Month

Markets This Month

Tata Motors, M&M top Sensex gainers  Full Article 

Google Drones

Google Drones

Google is testing unmanned drones to deliver anything from dog food to medicine.  Video 

#RiceBucketChallenge

#RiceBucketChallenge

In India, rice replaces ice in bucket challenge.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage